Access the full text.
Sign up today, get DeepDyve free for 14 days.
C-H. Hsu, Shen Yc, C. Yang, Kun-Huei Yeh, Y. Lu, C-H. Hsu, Liu Ht, Li Cc, Jen-Shi Chen, Chun-Ying Wu, Ann-Lii Cheng, Ann-Lii Cheng (2004)
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tractBritish Journal of Cancer, 90
MP Castro (1998)
Efficacy of gemcitabine in the treatment of patients with gallbladder: a case reportCancer, 82
B Glimelius, K Hoffman, PO Sjödén, G Jacobsson (1996)
Chemotherapy improves survival and quality of life in pancreatic and biliary tract cancerAnn Oncol, 7
(2002)
Folonic acid, and 5 Xuorouracil in advanced/unresectable adenocarcinoma of gall bladder: a pilot study
Tjokorda Suwardewa, Ketut Negara, Aan Kusuma, Aap Wiradnyana, Ryan Surya, I. Tunas (1995)
Case report.Journal, 12 3
E. Lazcano-Ponce, J. Miquel, N. Muñoz, R. Herrero, C. Ferrecio, I. Wistuba, P. Ruiz, Gerardo Urista, F. Nervi (2001)
Epidemiology and Molecular Pathology of Gallbladder CancerCA: A Cancer Journal for Clinicians, 51
C. Louvet, T. André, G. Lledo, Pascal Hammel, H. Bleiberg, C. Bouleuc, E. Gamelin, M. Flesch, Esteban Cvitkovic, A. Gramont (2002)
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 6
Tadahiro Takada, Hiroyuki Kato, Takashi Matsushiro, Yuji Nimura, T. Nagakawa, T. Nakayama (1994)
Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.Oncology, 51 5
DC Doval, JS Sekhon, SK Gupta, J. Fuloria, VK Shukla, S. Gupta, B. Awasthy (2004)
A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancerBritish Journal of Cancer, 90
T. Okusaka, H. Ishii, A. Funakoshi, K. Yamao, S. Ohkawa, S. Saito, H. Saito, T. Tsuyuguchi (2006)
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancerCancer Chemotherapy and Pharmacology, 57
J. Harder, B. Riecken, O. Kummer, C. Lohrmann, F. Otto, H. Usadel, Michael Geissler, Oliver Opitz, H. Henß (2006)
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancerBritish Journal of Cancer, 95
C Hsu, Y-C Shen, C-H Yang (2004)
Weekly gemcitabine plus 24 hour infusion of 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of biliary tractBr J Cancer, 90
Arundhati Sharma, R. Bedi, N. Shukla, V. Raina, B. Mohanti, S. Deo, N. Bedi, P. Garg, S. Thulkar, G. Rath (2004)
Does chemotherapy improve survival in gall bladder cancer?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14_suppl
T. Takada, Y. Nimura, H. Katoh, T. Nagakawa, T. Nakayama, T. Matsushiro, H. Amano, K. Wada (1998)
Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.Hepato-gastroenterology, 45 24
B. Glimelius, K. Hoffman, P. Sjödén, G. Jacobsson, H. Sellstrom, L. Enander, T. Linné, C. Svensson (1996)
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 7 6
J. Knox, D. Hedley, A. Oza, R. Feld, L. Siu, E. Chen, M. Nematollahi, G. Pond, Jessica Zhang, M. Moore (2005)
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 10
MO Perpetuo, M Valdivieso, LK Heilbrun (1978)
Natural history study of gallbladder cancer: a review of 36 years experience at M.D. Anderson Cancer CenterCancer, 42
T. André, C. Tournigand, O. Rosmorduc, S. Provent, F. Maindrault-Goebel, D. Avenin, F. Selle, F. Paye, L. Hannoun, S. Houry, B. Gayet, J. Lotz, A. Gramont, C. Louvet (2004)
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.Annals of oncology : official journal of the European Society for Medical Oncology, 15 9
M. Perpetuo, M. Valdivieso, L. Heilbrun, R. Nelson, Thomas Connor, G. Bodey (1978)
Natural history study of gallbladder cancer. A review of 36 years experience at M. D. Anderson hospital and tumor instituteCancer, 42
J. Gallardo, M. Fodor, C. Gamargo, L. Orlandi (1998)
Efficacy of gemcitabine in the treatment of patients with gallbladder carcinomaCancer, 83
R. Riechelmann, C. Townsley, S. Chin, G. Pond, J. Knox (2007)
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancerCancer, 110
Sharma Atul, Bedi Rajeev, K Shukla Nootan (2004)
Does chemotherapy improves survival in gall bladder cancer?Proc Am Soc Clin Oncol, 362
M. Raderer, M. Hejna, J. Valencak, G. Kornek, G. Weinländer, E. Bareck, J. Lenauer, T. Brodowicz, F. Lang, W. Scheithauer (1999)
Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary CancerOncology, 56
J. Gallardo, B. Rubio, M. Fodor, L. Orlandi, M. Yáñez, C. Gamargo, M. Ahumada (2001)
A phase II study of gemcitabine in gallbladder carcinoma.Annals of oncology : official journal of the European Society for Medical Oncology, 12 10
S. Thongprasert, S. Napapan, C. Charoentum, S. Moonprakan (2005)
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma.Annals of oncology : official journal of the European Society for Medical Oncology, 16 2
J. Gallardo, M. Fodor, C. Gamargo, L. Orlandi (1998)
Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report.Cancer, 83 11
T. André, J. Reyes-Vidal, L. Fartoux, P. Ross, M. Leslie, O. Rosmorduc, M. Clemens, C. Louvet, N. Perez, F. Mehmud, W. Scheithauer (2008)
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II studyBritish Journal of Cancer, 99
T André, C Tournigand, O Rosmorduc (2004)
GERCOR Group. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyAnn Oncol, 15
This combination of Oxigem effective in unresectable GBC. It may even induce complete pathological response. One-year survival was 20%. There is a need for controlled trial to assess efficacy of this combination.
Cancer Chemotherapy and Pharmacology – Springer Journals
Published: Feb 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.